|
| |
| | | 67757 | | 01.02.2021 | | Novartis Pharma Schweiz AG | | | | | | | 31.01.2026 | | | | | | | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Kesimpta | Injektionslösung in Fertigspritze | Injection solution in prefilled syringe (Ofatumumabum 20mg / 0.4ml) | L04AA52 | CI |
|
|
|
